Search
for
Sort by
Research 331–360 of 1000+
- Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management
- Congenital Adrenal Hyperplasia
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency
- Biology and Genetics of Hair
- Dermatoses of Pregnancy - Clues to Diagnosis, Fetal Risk and Therapy
- Applications of Mesenchymal Stem Cells in Skin Regeneration and Rejuvenation
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Cutaneous lupus erythematosus
- Toxic Epidermal Necrolysis
- Electrospun Nanofibers for Improved Angiogenesis: Promises for Tissue Engineering Applications
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- Ovarian leukocyte distribution and cytokine/chemokine mRNA expression in follicular fluid cells in women with polycystic ovary syndrome
- Air Pollution, Autophagy, and Skin Aging: Impact of Particulate Matter (PM10) on Human Dermal Fibroblasts
- Approach to the adult female patient with diffuse nonscarring alopecia
- Primary cicatricial alopecia
- Interventions for nail psoriasis
- CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata
- Induced Pluripotent Stem Cells from Human Hair Follicle Mesenchymal Stem Cells
- Acute diffuse and total alopecia: A new subtype of alopecia areata with a favorable prognosis
- Eczema-like, erythematous, infiltrated plaques: A common side effect of subcutaneous heparin therapy
- Frontal Fibrosing Alopecia: An Update on Pathogenesis, Diagnosis, and Treatment
- Adipose-derived cellular and cell-derived regenerative therapies in dermatology and aesthetic rejuvenation
- Genome-wide association study in Japanese females identifies fifteen novel skin-related trait associations
- GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk
- Nonclassic adrenal hyperplasia
- 46,XY DSD due to impaired androgen production
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study